Neuronal and Vascular Plasticity [electronic resource] : Elucidating Basic Cellular Mechanisms for Future Therapeutic Discovery /

Galen in the 2nd century AD could be considered one of the earliest researchers who attempted to bridge the gap between basic science and clinical medicine. Galen is given initial credit for the recognition that vital organs of the body are exquisitely dependent upon the intact function of the circulatory system. The doctrines of Galenic physiology stated that blood was produced in the liver, flowed to the heart to obtain "vital spirits", and subsequently bathed the brain to gain "animal spirits". The "vital spirits" described by Galen were later disclosed to consist of oxygen. Oxygen was discovered independently by Schiele in Sweden and by Priestly in England. It was named oxygen (acid-former) by Antoine Lavoisier (1743-1794) of France. Lavoisier made significant medical discoveries concerning oxygen's role in respiration. In animal experiments, Lavoisier and others discovered that anoxia could rapidly lead to death. The initial work by these investigators helped provide direction for modern clinical science and the treatment of disease, especially concerning disorders of the nervous system. Remarkably, our understanding of human disease continues to grow at an exponential rate. At times, the accumulation of knowledge of the cellular components of clinical disease exceeds all prior expectations held just a few years ago, such as evidenced by the recent cloning of the human and mouse genomes. Despite theses advances, both biomedical scientists and clinicians sometimes are at a loss to recognize the crucial link between basic science discovery and the development of therapeutic regiments for clinical disease.

Saved in:
Bibliographic Details
Main Authors: Maiese, Kenneth. editor., SpringerLink (Online service)
Format: Texto biblioteca
Language:eng
Published: Boston, MA : Springer US : Imprint: Springer, 2003
Subjects:Medicine., Neurosciences., Neurology., Biomedicine.,
Online Access:http://dx.doi.org/10.1007/978-1-4615-0282-1
Tags: Add Tag
No Tags, Be the first to tag this record!
id KOHA-OAI-TEST:220642
record_format koha
institution COLPOS
collection Koha
country México
countrycode MX
component Bibliográfico
access En linea
En linea
databasecode cat-colpos
tag biblioteca
region America del Norte
libraryname Departamento de documentación y biblioteca de COLPOS
language eng
topic Medicine.
Neurosciences.
Neurology.
Biomedicine.
Neurosciences.
Neurology.
Medicine.
Neurosciences.
Neurology.
Biomedicine.
Neurosciences.
Neurology.
spellingShingle Medicine.
Neurosciences.
Neurology.
Biomedicine.
Neurosciences.
Neurology.
Medicine.
Neurosciences.
Neurology.
Biomedicine.
Neurosciences.
Neurology.
Maiese, Kenneth. editor.
SpringerLink (Online service)
Neuronal and Vascular Plasticity [electronic resource] : Elucidating Basic Cellular Mechanisms for Future Therapeutic Discovery /
description Galen in the 2nd century AD could be considered one of the earliest researchers who attempted to bridge the gap between basic science and clinical medicine. Galen is given initial credit for the recognition that vital organs of the body are exquisitely dependent upon the intact function of the circulatory system. The doctrines of Galenic physiology stated that blood was produced in the liver, flowed to the heart to obtain "vital spirits", and subsequently bathed the brain to gain "animal spirits". The "vital spirits" described by Galen were later disclosed to consist of oxygen. Oxygen was discovered independently by Schiele in Sweden and by Priestly in England. It was named oxygen (acid-former) by Antoine Lavoisier (1743-1794) of France. Lavoisier made significant medical discoveries concerning oxygen's role in respiration. In animal experiments, Lavoisier and others discovered that anoxia could rapidly lead to death. The initial work by these investigators helped provide direction for modern clinical science and the treatment of disease, especially concerning disorders of the nervous system. Remarkably, our understanding of human disease continues to grow at an exponential rate. At times, the accumulation of knowledge of the cellular components of clinical disease exceeds all prior expectations held just a few years ago, such as evidenced by the recent cloning of the human and mouse genomes. Despite theses advances, both biomedical scientists and clinicians sometimes are at a loss to recognize the crucial link between basic science discovery and the development of therapeutic regiments for clinical disease.
format Texto
topic_facet Medicine.
Neurosciences.
Neurology.
Biomedicine.
Neurosciences.
Neurology.
author Maiese, Kenneth. editor.
SpringerLink (Online service)
author_facet Maiese, Kenneth. editor.
SpringerLink (Online service)
author_sort Maiese, Kenneth. editor.
title Neuronal and Vascular Plasticity [electronic resource] : Elucidating Basic Cellular Mechanisms for Future Therapeutic Discovery /
title_short Neuronal and Vascular Plasticity [electronic resource] : Elucidating Basic Cellular Mechanisms for Future Therapeutic Discovery /
title_full Neuronal and Vascular Plasticity [electronic resource] : Elucidating Basic Cellular Mechanisms for Future Therapeutic Discovery /
title_fullStr Neuronal and Vascular Plasticity [electronic resource] : Elucidating Basic Cellular Mechanisms for Future Therapeutic Discovery /
title_full_unstemmed Neuronal and Vascular Plasticity [electronic resource] : Elucidating Basic Cellular Mechanisms for Future Therapeutic Discovery /
title_sort neuronal and vascular plasticity [electronic resource] : elucidating basic cellular mechanisms for future therapeutic discovery /
publisher Boston, MA : Springer US : Imprint: Springer,
publishDate 2003
url http://dx.doi.org/10.1007/978-1-4615-0282-1
work_keys_str_mv AT maiesekennetheditor neuronalandvascularplasticityelectronicresourceelucidatingbasiccellularmechanismsforfuturetherapeuticdiscovery
AT springerlinkonlineservice neuronalandvascularplasticityelectronicresourceelucidatingbasiccellularmechanismsforfuturetherapeuticdiscovery
_version_ 1756270191343304704
spelling KOHA-OAI-TEST:2206422018-07-30T23:58:05ZNeuronal and Vascular Plasticity [electronic resource] : Elucidating Basic Cellular Mechanisms for Future Therapeutic Discovery / Maiese, Kenneth. editor. SpringerLink (Online service) textBoston, MA : Springer US : Imprint: Springer,2003.engGalen in the 2nd century AD could be considered one of the earliest researchers who attempted to bridge the gap between basic science and clinical medicine. Galen is given initial credit for the recognition that vital organs of the body are exquisitely dependent upon the intact function of the circulatory system. The doctrines of Galenic physiology stated that blood was produced in the liver, flowed to the heart to obtain "vital spirits", and subsequently bathed the brain to gain "animal spirits". The "vital spirits" described by Galen were later disclosed to consist of oxygen. Oxygen was discovered independently by Schiele in Sweden and by Priestly in England. It was named oxygen (acid-former) by Antoine Lavoisier (1743-1794) of France. Lavoisier made significant medical discoveries concerning oxygen's role in respiration. In animal experiments, Lavoisier and others discovered that anoxia could rapidly lead to death. The initial work by these investigators helped provide direction for modern clinical science and the treatment of disease, especially concerning disorders of the nervous system. Remarkably, our understanding of human disease continues to grow at an exponential rate. At times, the accumulation of knowledge of the cellular components of clinical disease exceeds all prior expectations held just a few years ago, such as evidenced by the recent cloning of the human and mouse genomes. Despite theses advances, both biomedical scientists and clinicians sometimes are at a loss to recognize the crucial link between basic science discovery and the development of therapeutic regiments for clinical disease.1 Transformation into Treatment: Novel Therapeutics that Begin Within the Cell -- 2 Cholinergic Plasticity and the Meaning of Death -- 3 Restorative Potential of Angiogenesis After Ischemic Stroke -- 4 Vascular Endothelial Function: Role of Gonadal Steroids -- 5 Alterations of Synaptic Transmission Following Transient Cerebral Ischemia -- 6 The Future of Brain Protection: Natural Alternatives -- 7 Iron S Involvement in the Molecular Mechanisms and Pathogenesis of Alzheimer S Disease -- 8 Ethanol-Induced Neurodegeneration: Basic Mechanisms and Therapeutic Approaches -- 9 Regulation of Neural Stem Cells in the Adult Mammalian Brain -- 10 G-Protein Mediated Metabotropic Receptors Offer Novel Avenues in Neuronal and Vascular Cells for Cytoprotective Strategies.Galen in the 2nd century AD could be considered one of the earliest researchers who attempted to bridge the gap between basic science and clinical medicine. Galen is given initial credit for the recognition that vital organs of the body are exquisitely dependent upon the intact function of the circulatory system. The doctrines of Galenic physiology stated that blood was produced in the liver, flowed to the heart to obtain "vital spirits", and subsequently bathed the brain to gain "animal spirits". The "vital spirits" described by Galen were later disclosed to consist of oxygen. Oxygen was discovered independently by Schiele in Sweden and by Priestly in England. It was named oxygen (acid-former) by Antoine Lavoisier (1743-1794) of France. Lavoisier made significant medical discoveries concerning oxygen's role in respiration. In animal experiments, Lavoisier and others discovered that anoxia could rapidly lead to death. The initial work by these investigators helped provide direction for modern clinical science and the treatment of disease, especially concerning disorders of the nervous system. Remarkably, our understanding of human disease continues to grow at an exponential rate. At times, the accumulation of knowledge of the cellular components of clinical disease exceeds all prior expectations held just a few years ago, such as evidenced by the recent cloning of the human and mouse genomes. Despite theses advances, both biomedical scientists and clinicians sometimes are at a loss to recognize the crucial link between basic science discovery and the development of therapeutic regiments for clinical disease.Medicine.Neurosciences.Neurology.Biomedicine.Neurosciences.Neurology.Springer eBookshttp://dx.doi.org/10.1007/978-1-4615-0282-1URN:ISBN:9781461502821